Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-24-005086
Filing Date
2024-11-14
Accepted
2024-11-14 15:29:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 armistice-evax093024.htm SC 13G 88943
  Complete submission text file 0001172661-24-005086.txt   90484
Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 004531262615
Evaxion Biotech A/S (Subject) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94294 | Film No.: 241461010
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)